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Abstract: The historical development of discoveries and conceptual frames for understanding the
hemorrhagic activity induced by viperid snake venoms and by hemorrhagic metalloproteinases
(SVMPs) present in these venoms is reviewed. Histological and ultrastructural tools allowed
the identification of the capillary network as the main site of action of SVMPs. After years of
debate, biochemical developments demonstrated that all hemorrhagic toxins in viperid venoms are
zinc-dependent metalloproteinases. Hemorrhagic SVMPs act by initially hydrolyzing key substrates
at the basement membrane (BM) of capillaries. This degradation results in the weakening of the
mechanical stability of the capillary wall, which becomes distended owing of the action of the
hemodynamic biophysical forces operating in the circulation. As a consequence, the capillary wall is
disrupted and extravasation occurs. SVMPs do not induce rapid toxicity to endothelial cells, and
the pathological effects described in these cells in vivo result from the mechanical action of these
hemodynamic forces. Experimental evidence suggests that degradation of type IV collagen, and
perhaps also perlecan, is the key event in the onset of microvessel damage. It is necessary to study this
phenomenon from a holistic, systemic perspective in which the action of other venom components is
also taken into consideration.
Keywords: snake venom; viperids; metalloproteinases; hemorrhage; capillary vessels; basement
membrane; type IV collagen
1. Introduction
Snakebite envenoming constitutes a highly relevant, albeit largely neglected, public health
problem on a global basis, affecting primarily impoverished populations in the rural settings of
Africa, Asia, Latin America and parts of Oceania [1–3]. Although accurate statistics on incidence
and mortality due to snakebite envenoming are scarce, it has been estimated that between 1.2 and
5.5 million people suffer snakebite envenomings every year, with 25,000 to 125,000 deaths, and an
estimated number of 400,000 victims left with permanent sequelae [4,5].
The clinical manifestations of envenomings vary depending on the species of snake causing the
bite, and there is a large spectrum of pathophysiological effects induced by snake venoms, owing to
the diverse arsenal described in their composition [6]. In addition, other factors play a key role in the
severity of envenomings, such as the volume of venom injected, the anatomical site of the bite, and the
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physiological characteristics of the affected person [2]. Envenomings by snakes of the family Viperidae,
and by some species of the family “Colubridae” (sensu lato), are characterized by prominent local and
systemic hemorrhage. Blood vessel damage leading to extravasation, in turn, contributes to local tissue
damage and poor muscle regeneration, and to massive systemic blood loss leading to hemodynamic
disturbances and cardiovascular shock [2,7].
The study of the mechanism by which snake venoms induce hemorrhage and the characterization
of hemorrhagic toxins and their mechanism of action has been a fascinating area of research within the
field of Toxinology. The present contribution summarizes the journey of discovery and understanding
that has led to our current view of snake venom-induced hemorrhage, and highlights some of the
seminal discoveries and hypotheses generated during more than a century of scientific efforts.
2. Describing the Occurrence of Hemorrhage in Clinical and Experimental Viperid
Snakebite Envenomings
Hemorrhage was recognized as a frequent and relevant manifestation early on in the description
of the main clinical features of viperid snakebite envenomings, and bleeding in various organs was
identified as one of the most serious consequences of these envenomings (see for example [8–10]). At
the experimental level, J.B. de Lacerda, in 1884 [11], working in Brazil, described the effects induced by
Bothrops sp. venoms in experimental animals. In his recount on local pathological effects, he reported
that “Le tissu cellulaire sous-cutané, est tout infiltré et présente de place en place des taches noiràtres, des points
violacés et épars, des nuances livides diffuses et de nombreuses extravasions sanguines . . . Le tissu cellulaire, qui
cuvre les muscles, est également infiltré, il offre un aspect gélatineux et est plus ou moins imbibé du sang noir,
en partie coagulé”. Two years later, Mitchel and Reichert, in the USA, described hemorrhagic events
in animals treated with viperid snake venoms [12]. When reporting an experiment performed in a
rabbit, the authors stated that “On the peritoneum were placed a few small particles of the dried venom of
Crotalus adamanteus. In two or three minutes some extravasations appeared immediately about the point of
the application of the venom; a few moments later these extravasations were diffused over a considerable area and
had run into each other to such an extent as to form a patch of bleeding surface”.
Other scientists investigated the hemorrhagic activity of viperid snake venoms in the first half of
the 20th century by describing macroscopic observations in affected tissues, and by introducing the
histological analysis of hemorrhagic lesions in organs. Likewise, researchers demonstrated the action
of viperid venoms on the coagulation system and on platelets, and speculated on the contribution of
these effects in the pathogenesis of venom-induced hemorrhage (reviewed in [13]). Thus hemorrhagic
activity of snake venoms was a topic of interest for early clinical and experimental toxinologists
owing to the relevance of hemorrhagic manifestations in the overall pathophysiology of viperid
snakebite envenoming.
3. Devising Methods to Quantify Venom-Induced Hemorrhage
The experimental study of venom-induced hemorrhage and the identification of hemorrhagic
components in snake venoms demanded the development of simple methods to quantify the extent
of hemorrhagic lesions. One of the most significant advances towards this goal was achieved by the
group of Akira Ohsaka in Japan [14]. A method was developed, consisting in the intracutaneous
injection of various amounts of venom of Trimeresurus (now Protobothrops) flavoviridis into the depilated
back skin of rabbits, followed by the measurement, 24 h later, of the size of the hemorrhagic spots in
the inner side of the skin. The log dose–response curves showed that linear responses were obtained
within a range of diameters from 10 mm to 18 mm. This skin method was then adapted for use in
rats [15] and mice [16–18], with variations in the time lapse between venom injection and observation
of hemorrhagic lesions. The hemorrhagic activity of a venom or toxin is expressed as the Minimum
Hemorrhagic Dose (MHD), usually defined as the dose of venom or toxin that induces a hemorrhagic
spot of 10 mm diameter [15,18]. This method has the limitation that it does not take into consideration
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the intensity of the hemorrhagic area, only its size. This has been circumvented by the quantification
of the hemoglobin present in the hemorrhagic area of the skin [19].
Other methods for quantification of venom-induced hemorrhagic activity have been
described [20], but modifications of the skin-based method of Kondo et al. [14] have been predominantly
used in toxinological research owing to its simplicity and quantitative nature. It has been particularly
useful in the assessment of hemorrhagic activity during fractionation of snake venoms for the
purification of hemorrhagic components. On the other hand, methods have been established for
the quantification of hemorrhagic activity by snake venoms in organs. The simplest one is based on
the intramuscular or intravenous injection of venoms in mice followed by the euthanasia of animals
and the sampling of affected organs. Tissues are then homogenized and the amount of hemoglobin
in the tissue is quantified spectrophotometrically, by recording the absorbance at 540 nm [18,21].
For the quantification of hemorrhagic activity of venoms in the lungs, in addition to the method of
Bonta et al. [20], the estimation of the Minimum Pulmonary Hemorrhagic Dose (MPHD) has been used.
For this, groups of mice are injected intravenously with various doses of venom or toxin. After one
hour, animals are euthanized and the thoracic cavity opened for observation of hemorrhagic spots in
the surface of the lungs. The MPHD corresponds to the lowest venom dose which induces hemorrhagic
lesions in the lungs in all mice injected [22].
4. Characterizing the Biochemical Properties of Hemorrhagic Toxins Present in Snake Venoms
Flexner and Noguchi [23] used the term “haemorrhagin” to denote the principle in snake venom
responsible for hemorrhagic activity, and described it as “the chief toxic constituent in Crotalus venom”.
By the middle of the 20th century, the hemorrhagic activity of viperid venoms was attributed by
several researchers to the proteolytic activity of venoms [24], although the evidence for this hypothesis
was mainly the fact that venoms with hemorrhagic activity also had high proteolytic action (see [13]).
In addition, the inhibition of hemorrhagic activity by incubation with the chelating agent EDTA
underscored the role of proteolytic activity in this effect [25]. However, it was not until modern
chromatographic procedures were introduced in the study of snake venoms that this issue was
properly addressed.
The early attempts to purify hemorrhagic toxins from snake venoms, by using electrophoretic and
chromatographic methods, resulted in the isolation of proteinases devoid of hemorrhagic activity and
of hemorrhagic toxins either having or lacking proteinase activity [26–28]. Thus, it was not completely
clear at that time whether all viperid hemorrhagic toxins were proteinases or not. A source of confusion
in these studies was the selection of the substrates for testing proteinase activity, as many of them
followed the method of Kunitz [29], which uses casein as substrate, and assesses proteolytic activity by
detecting acid-soluble peptides after precipitation of the enzyme-substrate mixture with trichloroacetic
acid. Owing to the substrate specificity of snake venom hemorrhagic principles, this method is unable
to detect proteolytic activity in some cases [30].
The advent of modern chromatographic procedures, especially after the decade of 1960, paved the
way for the isolation of hemorrhagic components of good purity from a variety of viperid snake venoms.
Among others, significant contributions in the purification of these components were performed by A.
Ohsaka and colleagues in Japan [13], Grotto et al. in Israel [27], and F.R. Mandelbaum and coworkers
in Brazil [31]. In 1978, Jon B. Bjarnason and Anthony T. Tu published a landmark study on the
characterization of five hemorrhagic toxins from the venom of the rattlesnake Crotalus atrox [17]. Instead
of employing the Kunitz’s casein method for assaying proteolytic activity, they used dimethylcasein
as substrate, which has a higher sensitivity. They demonstrated that these hemorrhagic toxins were
metalloproteinases containing one mol of zinc per mol of toxin. Chelating agents eliminated both
proteinase and hemorrhagic activities and, when zinc was removed, the toxins lost both actions to
a similar degree. As there was not a correlation between the extent of hemorrhagic and proteinase
activities, the authors suggested that these toxins have a highly selective substrate specificity for
inducing hemorrhage. This study clarified a number of apparent contradictions in the characterization
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of snake venom hemorrhagic components, and paved the way for a new age in the biochemical
characterization of hemorrhagic toxins.
Thereafter, many hemorrhagic proteinases, currently known as “snake venom metalloproteinases”
(SVMPs), have been purified and characterized from snake venoms (see reviews [32,33]). All
hemorrhagic SVMPs are zinc-dependent proteolytic enzymes that, together with the ADAMS
(“a disintegrin and metalloproteinase”) belong to the M12B family of metalloproteinases which, in
turn, are grouped within the Metzincin clan, characterized by a canonical sequence in the zinc-binding
region at the catalytic site and by a Met-turn [34]. SVMPs have been classified in three classes (PI, PII,
and PIII) on the basis of their domain composition. In the mature protein, PI SVMPs comprise the
metalloproteinase domain only, whereas PII SVMPs present a disintegrin (Dis) domain in addition
to the catalytic domain. On the other hand, PIII SVMPs present metalloproteinase, disintegrin-like
(Dis-like), and cysteine-rich (Cys-rich) domains. In turn, several subclasses have been described
within each class, depending on whether they are monomers or homo- or heterodimers, and also
on the variable patterns of post-translational cleavage of several domains [35]. The variations in
domain composition between different classes of SVMPs have implications in the mechanism of
action of hemorrhagic toxins (see Section 9 of this review). The detailed analysis of the biochemical
characterization of SVMPs, as well their molecular evolution after the recruitment of an ADAM-like
gene early on in the course of advanced snakes diversification are beyond the scope of this review;
readers are referred to excellent publications on these topics [33,35,36].
5. Exploring the Pathological Effects Induced by Venoms and SVMPs on the Microvasculature
One of the first histological analyses of snake venom-induced hemorrhage was published by
Taube and Essex [37]. It was observed that rattlesnake venom affected the integrity of endothelial
cells in vessels, inducing them to swell, and then burst and dissolve, leaving gaps in the vessel walls.
Moreover, the authors described loss in blood coagulability. Further histological studies described
hemorrhage, i.e., presence of erythrocytes in the interstitial space of various tissues, as a consequence
of injection of viperid venoms [38]. These authors also described pathological changes in the arterial
walls. However, the characterization of the precise morphological alterations induced by venoms in
the structure of microvessels had to wait for ultrastructural studies using the transmission electron
microscope (TEM). Early TEM observations in tissues injected with a purified hemorrhagic toxin
and the venom of T. flavoviridis revealed erythrocytes escaping through the intercellular junctions at
the endothelial cell lining [39]. It was proposed that the basement membrane (BM) adjacent to the
intercellular junctions has to be disrupted to allow the extravasation [13]. Moreover, by observing the
mesentery of rats using cinematographic techniques at the microscope, Ohsaka et al. [40] described
an initial vasoconstriction of arterioles, followed by vasodilation and then by the extravasation of
erythrocytes one by one through holes formed in the capillaries, but without an overt rupture of the
endothelium. Taken together, these findings suggested that hemorrhage occurs by extravasation of
erythrocytes through openings in the intercellular endothelial cell junctions. As to the mechanisms of
this opening, it was suggested that inflammatory mediators released by hemorrhagic toxins, such as
histamine, serotonin and others, are responsible for this phenomenon [13].
A different picture emerged with a detailed characterization of ultrastructural alterations
in capillary vessels after a subcutaneous injection of a hemorrhagic toxin from the venom of
Vipera palestinae (currently Daboia palestinae) [41]. Ultrastructural lesions were described in capillary
endothelial cells, and erythrocytes escaped through damaged endothelial cells and not through
widened intercellular junctions. Similar and more detailed ultrastructural observations were carried
out in muscle tissue injected with hemorrhagic SVMPs and crude venom of Crotalus atrox [42,43]. When
examining the morphology of affected capillaries, endothelial cells showed dilatation of endoplasmic
reticulum, formation of blebs, intracellular swelling, drop in the number of pinocytotic vesicles and,
most importantly, disruption and formation of gaps within the cells through which erythrocytes
escaped. The basal lamina was damaged in some portions and, interestingly, intercellular junctions
Toxins 2016, 8, 93 5 of 19
between endothelial cells were not affected. Ownby et al. [42,43] named this mechanism “hemorrhage
per rhexis”, in contrast with the mechanism proposed by Ohsaka and colleagues, which was named
“hemorrhage per diapedesis”.
Afterwards, a number of groups investigated the morphological alterations in the
microvasculature associated with the action of hemorrhagic SVMPs [22,44–47]. All of them described
the extravasation of erythrocytes through lesions in capillary endothelial cells, and not through
widened intercellular junctions, thus supporting the mechanism of hemorrhage per rhexis. (Figure 1).
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Figure 1. Pathological effects induced by a hemorrhagic snake venom metalloproteinase (SVMP) in
capillary vessels. (A) Electron micrograph of a capillary vessel from muscle tissue injected with saline
solution. Normal ultrastructure is observed in endothelial cell, including the presence of pynocytotic
vesicles, and basement membrane (arrow). (B) Micrograph of a section of tissue injected with the
hemorrhagic SVMP BaP1, from the venom of Bothrops asper. Notice prominent damage of endothelial
cell, with loss of pynocytotic vesicles, distention a d thinning of the cell, and rupt re of cell integrity at
one point (arrowhead). The basement embrane is absent along most of the periphery of the capillary
(arrow). An erythrocyte (E) and a neutrophil (N) are bserved inside th ssel. Magnification:
17,000ˆ (A); a d 1 ,000ˆ (B). Reproduced by [47], Copyright 2006, Elsevier.
In contrast, Gonçalves and Mariano [48] described hemorrhage per diapedesis in the rat
subcutaneous tissue injected with the venom of Bothrops jararaca. An explanation for this apparent
discrepancy was proposed by Gutiérrez et al. [49]. It was suggested that the predominant mechanism
of extravasation depends on the type of microvessel being observed. In electron micrographs of
capillary vessels, endothelial cell disruption occurs and per rhexis mechanism predominates. In
contrast, in the studies of Ohsaka [13] and Gonçalves and Mariano [48], the affected microvessels
shown in the micrographs in which erythrocytes escape through widened intercellular junctions are
venules. Venules react to several inflammatory mediators by contraction and widening of intercellular
junctions, leading to an increment in vascular permeability [50]. It has been described that erythrocyte
extravasation may take place by the intercellular route in cases of intense inflammation [51], as occurs
in snakebite envenoming. Thus, both mechanisms of extravasation, i.e., per rhexis and per diapedesis, are
likely to be involved in tissues as a consequence of the action of hemorrhagic SVMPs. In the case of
skeletal muscle, ultrastructural observations strongly indicate that per rhexis mechanism predominates,
and that the main locus of action of SVMPs is the capillary network, and not the venular part of
the microvasculature.
Intravital microscopy has been a useful tool to investigate the actions of venom and toxins in
tissues from a dynamic perspective. When the venom of Bothrops asper or isolated SVMPs from this
venom have been applied to the mouse cremaster muscle, microhemorrhagic lesions were observed in
capillary vessels few minutes after application [52,53]. These microbleedings occurred in an explosive
fashion and resulted in burst-shaped microhematomas. As time passed, more microhematomas
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appeared in the capillary network. These observations tend to support the per rhexis mechanism of
hemorrhage, since such microvascular hemorrhagic bursts are more compatible with a rupture in the
integrity of the capillary wall than with a discrete extravasation of erythrocytes through widened
intercellular junctions.
6. Are Endothelial Cells Directly Damaged by Hemorrhagic SVMPs? A Two-Step Hypothesis
and the Role of Biophysical Factors Operating in Vivo
The described ultrastructural observations of microvessels affected by SVMPs, occurring within
few minutes of injection, highlight a prominent early damage to endothelial cells in vivo. An obvious
corollary of these observations is that hemorrhagic SVMPs are directly cytotoxic to endothelial cells.
However, when SVMPs are incubated with endothelial cells in culture, no cytotoxicity is observed
during the first hours of incubation, in contrast to the very rapid damage observed in these cells
in vivo, which occurs within minutes [53–56]. The most evident consequence of the action of SVMPs
on endothelial cells in culture is a detachment of these cells, as a consequence of cleavage of proteins
in the substrate of culture wells [53–55]. Interestingly, detached cells remain viable several hours until,
eventually, they undergo cell death by apoptosis. A number of SVMPs have been described to induce
apoptosis in endothelial cells in culture [57–60]. It was proposed that apoptosis occurs by anoikis, i.e.,
as a consequence of the detachment of cells from their substrate [59,60], although the observation of
SVMP-induced cytotoxicity in non-adherent cells in suspension argues for other mechanisms of cell
death in addition to anoikis [61]. The cellular mechanisms involved in SVMP-induced endothelial cell
apoptosis have been explored in detail by several groups (see for example [58–62]).
The use of endothelial cell monolayers in culture as a model to investigate the action of SVMPs
has the drawback that, phenotypically, these cells bear differences with microvascular endothelial cells
in vivo. Baldo et al. [63] approached this limitation by using two-dimensional and three-dimensional
cultures of endothelial cells in an extracellular matrix scaffold, this model being closer to the in vivo
conditions of vascular endothelial cells. It was observed that collagen and Matrigel substrates enhanced
endothelial cell damage induced by a hemorrhagic SVMP, allowing the binding of this enzyme to focal
adhesions, disruption of stress fibers, detachment and apoptosis. This study stressed the relevance of
developing in vitro models of endothelial cells which more closely resemble their phenotype in vivo.
Nevertheless, even in these conditions, cytotoxic effects on endothelial cells appear after several hours
and, therefore, do not reproduce the very early necrotic damage occurring in the microvasculature
in vivo after injection of hemorrhagic SVMPs.
A hypothesis was proposed by Gutiérrez et al. [49] to explain this apparent discrepancy, by
taking into consideration the possible role of the hemodynamic biophysical forces operating in the
circulation in vivo, i.e., wall tension and shear stress. According to Laplace’s law, wall tension is directly
proportional to transmural pressure, i.e., the difference between intravascular and extravascular
hydrostatic pressures, and to the radius of the vessel [64]. In turn, shear stress is directly proportional
to blood flow and viscosity, and inversely proportional to the vessel radius [65]. The distensibility
of the vascular wall plays a key role in wall tension. In the case of capillaries, such distensibility is
predominantly determined by the mechanical properties of their BM [66,67]. Thus, any effect in the
mechanical stability of the BM would have a direct impact in the distensibility of the capillary wall.
It was proposed by Gutiérrez et al. [49] that hemorrhagic SVMPs cause damage to the integrity of
capillary vessels by a two-step mechanism: Initially, these enzymes hydrolyze key substrates at the
BM surrounding endothelial cells in capillaries, causing a weakening in the mechanical stability of
BM and increasing the distensibility of the microvessel wall. As a second step, the hemodynamic
forces operating in the microcirculation, especially the hydrostatic force, induce a distention in the
wall, which eventually culminates in the disruption of its integrity and in extravasation (Figure 2).
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This hypothesis is compatible with ultrastructural alterations described above, i.e., an increase
in the capillary lumen associated ith a thinning of endothelial cells and a drop in the number
of pinocytotic vesicles, together with overt disruptions in the integrity of endothelial cells through
which blood escapes to the interstitial space. One prediction arising from this hypothesis is that
capillary damage should not occur in conditions of absence of blood flow. This was corroborated at
the experimental level in muscle tissue of mice injected with a hemorrhagic SVMP in which blood flow
was totally interrupted; no endothelial cell damage was observed in these conditions [47]. Thus, the
rapid endothelial cell damage caused by hemorrhagic SVMPs in vivo is not due to a direct action of
these enzymes in the cells, but instead to an indirect effect as a consequence of the weakening of the
mechanical stability of the capillary wall owing to the effect of SVMP on the BM components. The
obvious questions are, then: How do hemorrhagic SVMPs affect the B ? Why are some SVMP able to
induce hemorrhage while others are not?
Toxins 2016, 8, 93 8 of 19
7. Exploring the Hydrolysis of Basement Membrane Components by SVMPs
The biochemical characterization of hemorrhagic components in snake venoms demonstrated
that they are metalloproteinases. However, most of the early studies on purified SVMPs demonstrated
proteolytic activity on a variety of substrates that do not correspond to the physiological targets
of these enzymes [30,32]. Since microvessels are the target of hemorrhagic SVMPs, the study of
degradation of BM components became a relevant task in understanding SVMPs’ mechanism of
action. Ohsaka et al. [69] first demonstrated that hemorrhagic SVMPs hydrolyzed proteins of isolated
glomerular BM. In 1988, Bjarnason et al. [70] described the ability of SVMPs to hydrolyze proteins of
Matrigel, a BM preparation from Engelbreth–Holm–Swarm (EHS) mouse sarcoma, and on isolated BM
components. Since then, several studies have described the hydrolysis of BM components by a number
of SVMPs [53,71–77]. Notwithstanding, several puzzling findings arose from these observations:
(a) The time-course of SVMP-induced hydrolysis of BM components in vitro, as judged by SDS-PAGE,
usually take several hours, whereas hemorrhage in vivo appears within minutes; this could be explained
on the grounds that SDS-PAGE analysis may not reveal subtle, but significant, early cleavage of BM
components, which would be relevant for the weakening of BM stability. (b) Several SVMPs devoid or
having very low hemorrhagic activity have been shown to hydrolyze BM components in vitro [78–80].
This raises the possibility that a critical attack to the BM mechanical stability might be related to the
selective hydrolysis of some BM components.
The BM is a complex and highly specialized extracellular matrix structure which plays a
key scaffold role in capillary endothelial cells and in other cell types [81]. BM contains major
components such as laminin, type IV collagen, nidogen/entactin, and heparin sulphate proteoglycan
(perlecan), in addition to a number of minor components such as agrin, APARC/BM-40/osteopontin,
fibulins and types XV and XVIII collagens [81–83]. In the context of this complexity, which are the
structurally relevant components whose cleavage by hemorrhagic SVMPs weakens the mechanical
stability of microvessels? When comparing the hydrolysis of Matrigel in vitro by PI hemorrhagic and
non-hemorrhagic SVMPs, a significant difference was found on the hydrolysis of type IV collagen
and perlecan, since the former cleaved these substrates, particularly type IV collagen, to a greater
extent [80]. On these grounds, deciphering the sites of cleavage of these molecules might shed light on
the molecular basis of BM destabilization. Jay W. Fox, Jon Bjarnason and colleagues have studied the
cleavage patterns of Crotalus atrox hemorrhagic SVMP on type IV collagen [32,72]. Cleavage occurs
at the α1 (IV) and α2 (IV) chains. The α1 (IV) chains are cleaved at a triplet interruption region of
the triple helix, whereas the α2 (IV) chain is cleaved in the triple helical region near the NC2 domain.
Owing to the role of these sites in the association of type IV collagen monomers into tetramers, these
cleavages may have implications on the mechanical stability of the BM [32].
8. Exploring the Hydrolysis of BM Components by SVMPs in Vivo
The described in vitro observations of BM hydrolysis by SVMPs raised the need to explore
the degradation of BM components in vivo as a consequence of injection of SVMPs. This has been
approached by a combination of three methodologies, i.e., immunohistochemistry in tissue sections,
immunodetection by Western blot in tissue homogenates, and proteomics analysis of exudates collected
in the vicinity of affected tissue. These complementary approaches have provided novel clues for
understanding of the pathogenesis of SVMP-induced hemorrhage. Immunohistochemical staining of
BM components as early as 15 min after injection of hemorrhagic SVMPs revealed loss of staining in
microvessels of type IV collagen, laminin and nidogen [75,84], hence underscoring the rapid cleavage
of these proteins. Such degradation was corroborated when performing immunoblots for detection of
BM components on tissue homogenates and exudates [80,85]. Interestingly, when hemorrhagic and
non-hemorrhagic SVMPs were compared, a similar pattern of hydrolysis was observed for laminin
and nidogen, whereas the hemorrhagic enzyme induced a more extensive cleavage of perlecan and,
especially, type IV collagen [80] (Figure 3).
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Figure 3. Differential hydrolysis of basement membrane components in vivo by hemorrhagic and
non-hemorrhagic snake venom metalloproteinases (SVMPs). Non-hemorrhagic SVMP (leucurolysin
a-leuc) and hemorrhagic SVMP (BaP1) were injected in the muscle of mice. After 15 min, animals
were euthanized, and tissue was collected and homogenized. Supernatants of homogenates were
separated by SDS-PAGE, and transferred to nitrocellulose membranes for immunodetection with
either anti-laminin (A); anti-nidogen (B); anti-type IV collagen (C); and anti-endorepelin (perlecan)
(D) antibodies, and with anti-GAPDH as loading control. (C) Control muscle injected with saline
solution. A chemiluminiscent substrate was used to detect the reactions. Densitometric analysis was
then performed. The molecular mass of various markers (in kDa) is shown at the right of the gels.
A clear difference is observed between these SVMPs in the patterns of degradation of type IV collagen
and endorepelin (perlecan). Reproduced by [80], Copyright 2011, PLOS.
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Taken together, these findings strongly support the view that cleavage of type IV collagen, and
probably perlecan as well, play a key role in the weakening of the mechanical stability of the BM
of capillary vessels, and constitutes the first step in the pathogenesis of SVMP-induced microvessel
damage [68,80]. When immunoblotting experiments were performed with muscle homogenates
prepared from mice injected with a hemorrhagic SVMP in conditions where blood flow was interrupted,
similar degradation patterns of BM components were observed (our unpublished results), but the
integrity of capillary vessels was intact [47]. This supports the “two-step” hypothesis described above,
since in conditions of no blood flow, the first step occurs, i.e., enzymatic cleavage of BM components,
but the second one, i.e., distention and rupture of vessel integrity, does not, since the biophysical
hemodynamic forces dependent on blood flow are not operating in these circumstances.
A significant step forward in the study of venom-induced tissue damage was the introduction
of the proteomic analysis of exudate samples collected in the affected tissues [86], as well as of tissue
homogenates [87]. This experimental approach allowed the identification of cleavage products of
several extracellular matrix proteins, including BM components, as a consequence of the action of
SVMPs [80,85,86]. In addition, fragments of type VI and type XV collagens were detected [80,85,86].
Interestingly, the amount of BM-specific heparan sulfate proteoglycan core protein, type VI collagen
and type XV collagen were higher in exudates collected from tissue injected with a hemorrhagic SVMP
than in samples injected with a non-hemorrhagic enzyme [80], thus suggesting that cleavage of these
proteins may be related with the pathogenesis of hemorrhage. Type VI and XV collagens contribute
to the stabilization of capillary vessels by connecting the BM with the surrounding extracellular
matrix [88,89].
9. What Is the Basis for the Large Variation in the Hemorrhagic Potential of SVMPs?
When the hemorrhagic activity of isolated SVMPs is quantified, large differences are observed
between enzymes. Moreover, some SVMPs are able to induce systemic hemorrhage, whereas others
only cause local bleeding. The structural basis for these variations in hemorrhagic potential in enzymes
that, otherwise, have similar cleavage patterns on protein substrates, has been deciphered as the
structural features of SVMPs have become understood. In general, PIII SVMPs, which comprise Dis-like
and Cys-rich domains in addition to the metalloproteinase domain, are more potent hemorrhagic
toxins than PI SVMPs having only the catalytic domain [33,49]. Moreover, some of the few P-II
SVMPs characterized to date are also potent hemorrhagic enzymes [90,91]. Thus, it is evident that the
additional domains potentiate hemorrhagic activity, probably by the presence of relevant exosites in
their sequences.
These exosites may contribute to hemorrhagic activity in various ways. They may promote
the binding of SVMPs to specific substrates in the tissues at relevant targets, such as the capillary
microvascular network. Indeed, immunohistochemical evidence has demonstrated that PII and PIII
SVMPs preferentially bind to the microvasculature when applied in mouse tissues, and present a
pattern of co-localization with type IV collagen in the vessel wall [84,85] (Figure 4). The same pattern
of co-localization was observed for a fragment constituted by the Dis-like and Cys-rich domains (DC
fragment) of a PIII SVMP, confirming that sequences in these domains are responsible for the targeting
to microvessels [84]. In contrast, PI SVMPs, devoid of these additional domains, show a widespread
localization in the extracellular matrix and are not concentrated in the vessels [84,85].
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Figure 4. Immunolocalization of snake venom metalloproteinases (SVMPs) with vascular basement
membrane on mouse cremaster muscle. Groups of mice were euthanized, and the cremaster muscle was
dissected out. The isolated muscles were incubated for 15 min with equi-hemorrhagic amounts of three
different SVMPs: BaP1 (PI SVMP, 30 µg), BlatH1 (PII SVMP, 3.5 µg) or CsH1 (PIII SVMP, 15 µg) labeled
with Alexa Fluor® 647 (blue). Control tissues were incubated with the SVMPs without labeling and no
fluorescence was detected. Whole tissues were fixed with 4% paraformaldehyde and immunostained
with anti-collagen IV following the secondary antibody labeled with Alexa Fluor 488 (green). Tissues
were visualized in a Zeiss LSM 5 Pascal laser-scanning confocal microscope. Three-dimensional
reconstitution of the images was carried out using IMARIS ˆ64 7.4.2 software. (A) Distribution of
the SVMPs in the cremaster muscle tissue. Scale bar represents 150 µm. (B) Localization of SVMPs in
capillary vessels in the cremaster. Scale bar represents 20 µm. White areas represent co-localization of
the SVMPs (blue) with collagen IV (green) of vascular basement membrane in capillaries. Notice the
predominant localization of PII and PIII SVMPs in the vasculature, whereas PI SVMP localizes in a
more widespread fashion in the tissue. Reproduced by [85], Copyright 2015, PLOS.
Biochemical studies with jararhagin, a hemorrhagic PIII SVMPs from the venom of
Bothrops jararaca, showed that the Dis-like and Cys-rich domains mediate the binding to collagens
and α2β1 integrin, respectively [92,93]. Moreover, the Cys-rich domain of PIII SVMPs is responsible
for the binding to type I collagen and several proteins presenting von Willebrand factor (vWF) A
domains, such as vWF, various fibrillary-associated collagens with interrupted triple helices (FACITs)
and matrylins [94–96]. In light of the pathological and proteomic observations described above, the
binding to various fibrillar and non-fibrillar collagens are relevant, since hydrolysis of these substrates
is likely to be causally related to the onset of microvessel damage [68]. The fact that PII SVMPs are
also potent hemorrhagic toxins, and at least one of them co-localizes with type IV collagen in the
vessels [85], demonstrates that exosites located in the Dis domain allow the targeting of these SVMPs
to the microvasculature. Thus, by directing PII and PIII SVMPs to the microvessels, these additional
domains are likely to position the catalytic sites of these enzymes nearby relevant substrates in the
BM. In contrast, PI SVMPs are not targeted to these loci in the tissue and therefore are less effective in
causing capillary damage.
It has been also described that the generalist plasma proteinase inhibitor α2-macroglobulin (α2M)
effectively abrogates proteolytic and hemorrhagic activities of PI SVMPs, whereas it is ineffective
to inhibit these activities in PII and PIII SVMPs [91,97–100]. The structural basis for this difference
remains unknown, but it is likely that structural constraints in the Dis, Dis-like and Cys-rich domains
impair the inhibitory action of α2M. This finding is relevant in the light of the abilit of PII and PIII
SVMPs to i duce s stemic hemorrhage, since they are not i hibited upon their entrance i to the
circulation a their distribution to various organs. In contrast, PI SVMPs are readily i hibited by α2M
when they reach the bloodstream, thereby precluding their action at distant organs [49]. Moreover,
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PII and PIII SVMPs are able to inhibit platelet aggregation, owing to the action of sequences of their
Dis, Dis-like and Cys-rich domains [101], and also have the ability to degrade vWF [96,102]. However,
these effects on hemostasis have been shown in vitro, and it remains to be investigated whether they
also have an impact in vivo.
10. SVMP-Induced Hemorrhage Viewed from a Holistic Perspective: Studying the Action of
SVMP in the Context of the Whole Venom
The field of Toxinology, as many other areas in biomedical research, is moving from a
predominantly “reductionist” approach to a more “holistic” and integrated perspective [103]. In
this context, the characterization of the structural and functional properties of hemorrhagic SVMPs
has provided a rich body of knowledge that has expanded our understanding on the mechanism of
action of these toxins in the tissues and on the structural determinants of their activity. Nevertheless, in
actual snakebites, it is whole venom that is injected in the victim’s tissues and, consequently, the action
of toxins has to be analyzed in the context of venoms. Probably the best example of this need, in the
case of hemorrhagic activity of SVMPs, is the potentiation of this activity by venom components that
affect hemostasis. Viperid venoms contain an array of proteins acting on plasma coagulation factors
and platelets [2,101,104,105]. Serine proteinases and SVMPs exert procoagulant effects by displaying
thrombin-like activity, or by activating factors II, X or V of the coagulation cascade [106]. In vivo, these
procoagulant effects result in defibrinogenation and incoagulability [2,105]. Although incoagulability
per se does not necessarily result in significant bleeding, coagulopathy potentiates bleeding in the
context of SVMP-induced vascular damage. In some cases, the action of procoagulant components in
snake venoms or the damage to the endothelial lining cause regional thrombosis [107,108], with the
consequent local or remote ischemic events, which contribute to the complexity of the pathophysiology
of cardiovascular alterations in snakebite envenomings.
Likewise, various venom components, such as proteins of the C-type lectin-like family, and also
serine proteinases, SVMPs, and disintegrins, exert effects that impair platelet function, either by causing
thrombocytopenia or inhibition of platelet aggregation [101,109–112]. The role of venom-induced
platelet disturbances in potentiating hemorrhagic activity has been demonstrated clinically [113] and
at the experimental level, whereby mice rendered thrombocytopenic by a C-type lectin-like venom
component developed stronger hemorrhage in the lungs after injection with a hemorrhagic SVMP [114].
Less evident instances of synergisms between SVMPs and other venom components have been
also described. The co-administration of hyaluronidase and a hemorrhagic SVMP increased the
hemorrhagic area as compared to the action of the SVMP alone, thus suggesting that hyaluronidase
plays the role of a spreading factor that extends the action of SVMPs [115,116]. In this context, it
is relevant to consider the possible involvement of non-hemorrhagic SVMPs since these enzymes,
despite lacking hemorrhagic activity, degrade various extracellular matrix components [79]; this effect
might contribute to the spreading and action of hemorrhagic SVMPs, a hypothesis that requires
experimental analysis. More recently, a puzzling phenomenon was described whereby a non-toxic
venom phospholipase A2, which does not affect endothelial cells, potentiates the cell-detaching
effect induced by a hemorrhagic SVMP on an endothelial cell line in culture [117]. Moreover, the
inflammatory landscape generated by various components upon venom injection in the tissues is likely
to promote vascular alterations that might potentiate the disruptive effect of hemorrhagic SVMPs in
the microvasculature. The role of inflammation in the pathogenesis of systemic hemorrhage in organs
such as the lungs or the brain remains to be explored.
11. Concluding Remarks
This summarized account of the journey followed by toxinologists for understanding the
mechanisms by which SVMPs induce hemorrhage has provided an overview of some of the landmarks
in the characterization of SVMPs and their action in the microvasculature. It is now clear that
hemorrhage occurs mostly through the SVMP-induced degradation of key structural proteins at
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the BM and its surroundings. The mechanical weakening generated by this enzymatic degradation
results in microvessel wall distention owing to the action of the hemodynamic forces operating in the
circulation, with the eventual disruption of the capillary wall and extravasation. The wide variation in
the hemorrhagic potential of SVMPs of different domain composition has been explained by the role of
Dis, Dis-like and Cys-rich domains in positioning these enzymes at physiologically-relevant sites for
exerting their hemorrhagic activity, i.e., at the microvasculature. There is a need to explore, at deeper
levels, which are the BM components critical for the disruption of microvessel integrity; in this regard,
the use of immunoelectron microscopic techniques should provide novel information on the precise
localization of SVMPs in the BM. Likewise, the proteomic analysis of samples of exudate and tissue
collected after injection of SVMPs is likely to offer further details of the fine pathological alterations
induced by these enzymes. The use of diverse, and complementary, methodological platforms has
been helpful in generating valuable information on the mechanism of action of SVMPs, and should be
strengthened and expanded in the future.
On the other hand, the action of hemorrhagic SVMPs in the organism has to be studied from a
more holistic perspective, by understanding it in the overall context of envenoming. In this regard, the
study of pathological alterations caused by SVMPs has to be complemented with the study of these
effects induced by crude venoms and by combinations of various venom components, as well as by
understanding the role of tissue responses to envenoming in the pathogenesis of hemorrhage and
other pathological effects. The complexity of these tasks demands the integration of multidisciplinary
research tools, including informatic resources. Toxinology is in need of renewed conceptual and
experimental platforms aimed at reaching a more profound understanding of the highly complex
pathophysiology of snakebite envenoming, including the pathogenesis of hemorrhage.
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